维普期刊资源整合服务平台（V6.5）

121篇 您的检索式：作者名="Tinteren"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	FDG-PET/CT response evaluation during EGFR-TKI treatment in patients with NSCLC显示文摘Over recent years,[18F]-fluorodeoxyglucose positron emission tomography acquired together with low dose computed tomography(FDG-PET/CT)has proven its role as a staging modality in patients with non-small cell lung cancer(NSCLC).The purpose of this review was to present the evidence to use FDG-PET/CT for response evaluation in patients with NSCLC,treated with epidermal growth factor receptor(EGFR)-tyrosine kinase inhibitors(TKI).All published articles from 1November 2003 to 1 November 2013 reporting on 18FFDG-PET response evaluation during EGFR-TKI treatment in patients with NSCLC were collected.In total 7studies,including data of 210 patients were eligible for analyses.Our report shows that FDG-PET/CT responseduring EGFR-TKI therapy has potential in targeted treatment for NSCLC.FDG-PET/CT response is associated with clinical and radiologic response and with survival.Furthermore FDG-PET/CT response monitoring can be performed as early as 1-2 wk after initiation of EGFR-TKI treatment.Patients with substantial decrease of metabolic activity during EGFR-TKI treatment will probably benefit from continued treatment.If metabolic response does not occur within the first weeks of EGFR-TKI treatment,patients may be spared(further)unnecessary toxicity of ineffective treatment.Refining FDG-PET response criteria may help the clinician to decide on continuation or discontinuation of targeted treatment.	Matthijs H van Gool Tjeerd S Aukema Koen J Hartemink Renato A Valdés Olmos Houke M Klomp Harm van Tinteren	2014	World Journal of Radiology2014，6，7：	8
2	8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer显示文摘	Vic J. Verwaal MD PhD Sjoerd Bruin MD Henk Boot MD PhD Gooike Slooten MD Harm Tinteren ScM	2008	Annals of Surgical Oncology2008，，9：	3
3	8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer显示文摘	Vic J. Verwaal Sjoerd Bruin Henk Boot Gooike Slooten Harm Tinteren	2008	Annals of Surgical Oncology2008，，：	3
4	Active spectfic immunotherapy for stage Ⅱ and stage Ⅲ human colon cancer:a randomized trial 显示文摘	Vermorken JB Claessen AM Tinteren HV	1999	Lancet1999，353，：	1
5	Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial 显示文摘	van Tinteren H Hoekstra OS Smit EF	2002	Lancet2002，359，：	1
6	Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase Ⅲ randomised cairo study显示文摘	Koopman M Venderbosch S van Tinteren H	2009	Eur J Cancer2009，45，11：	1
7	P27Kip1 expression in breast carcinomas: an immunohistochemical study on 512 patients with long-term follow-up显示文摘	Barbareschi M Van Tinteren H Mauri FA	2000	Int J Cancer2000，89，：	1
8	Toxicity of cytore- ductive surgery and hyperthermic in- traperitoneal chemotherapy 显示文摘	Verwaal V J van Tinteren H Ruth S V Zoetmulder F A	2004	J Surg Oncol2004，85，2：	1
9	Malignant rhabdoid tumours of the kidney (MRTKs) , registered on recent SIOP protocols from 1993 to 2005: areport of the SlOP renal tumour study group 显示文摘	van den Heuvel-Eibrink MM van Tinteren H Rehorst H	2011	Pediatr Blood Cancer2011，56，：	1
10	Malignant rhabdoid turnouts of the kidney (MRTKs),registered on recent SIOP protocols from 1993 to 2005:a report of the SIOP renal tumour study group显示文摘	van den Heuvel-Eibrink MM van Tinteren H Rehorst H	2011	Pediatr Blood Cancer2011，56，5：	1
11	Sleep endoscopy versus modified Mallampati score in sleep apnea and snoring显示文摘	den Herder C van Tinteren H de Vries N	2005	Laryngoscope2005，115，4：	1
12	Effectiveness of position emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer显示文摘	Van tinteren H Hoekstra OS Smitt EF	2002	Lancet2002，359，：	1
13	Amplification of genes within the chromosome 1 l q13 region is indicative of poor prognosis inpatients with operable breast cancer显示文摘	SCHUURING E VERHOEVEN E van TINTEREN H	1992	Cancer Res1992，52，10：	1
14	Long-term impact of the 70-gene signature on breast cancer outcome显示文摘	Drukker CA van Tinteren H Schmidt MK	2014	Breast Cancer Res Treat2014，143，3：	1
15	Use of thoracic radiotherapy for extensive stage small-cell lung canc- er: a phase 3 randomised controlled trial 显示文摘	SLOTMAN B J Van TINTEREN H PRAAG J O	2015	Lancet2015，385，9962：	1
16	Postoperative serum proteomie profiles May predict recurrence-free sur- vival in high-risk primary breast Cancer显示文摘	Gast MC Zapatka M van Tinteren H	2011	J Cancer Res Clin Oncol2011，137，12：	1
17	Sleep endoscopy versus modified Mallampati score in sleep apnea and snoring显示文摘	den Herder C van Tinteren H de Vries N	2005	Laryngoscope2005，115，4：	1
18	Postoperative serum proteomic profiles may predict recurrence-free survival in high-risk primary breast cancer 显示文摘	Gast MC Zapatka M Tinteren H	2011	J Cancer Res Clin Onco12011，137，12：	1
19	Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase Ⅲ randomised CAIRO study 显示文摘	KOOPMAN M VENDERBOSCH S VAN TINTEREN H	2009	Eur J Cancer2009，45，11：	1
20	Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3) : a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group 显示文摘	SIMKENS L H VAN TINTEREN H MAY A	2015	Lancet2015，385，9980：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示